Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Mike Ward
Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q3 (8 quarters; questions recorded in 7).
- Questions
- 22on tracked calls
- Challenge rate
- 9%2 of 22 questions
- Companies
- 3questioned at least once
- Reporting periods
- 7with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right. See how we grade analysts on earnings-call questions.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 22 of 22 questions from 3 companies
PRUPrudential Financial9 questions · 5 reporting periods · 1 of 9 challenging
Calendar 2026 Q2
dig in specifically a little bit more into the capabilities or kind of types of assets in asset management or for PGIM that you might be particularly interested in
Show response
Sullivan said the priority is building on PGIM's credit strength, then higher-growth areas like infrastructure equity and private equity, globalizing the platform beyond the ~25% of business currently sourced outside the US, and growing retail organically via ETFs.
can you expand on anything that gives you confidence in your ability to resume and continue growth and new business production
Show response
Sullivan expressed confidence in Japan, a 40-year franchise where POJ was historically ~40% of Japan sales, citing resilient earnings, a broad product portfolio, expanded yen-based and retirement offerings selling well in other channels, and society's desire for Prudential to succeed.
Calendar 2026 Q1
longer term, should we expect some free cash flow and ESR impact
Show response
Del Frias explained Japan cash flows follow statutory not GAAP, so $1B GAAP impact does not flow through. Once sales resume, LP subsidy ends and offsets new-business capital, limiting long-term impact.
you specifically mentioned macro-driven uncertainty driving claim incidence and severity
Show response
Sullivan explained LTD incidence driven by large employer layoffs affecting white-collar book. Also cited lower claim resolutions in the quarter. Emphasized century of cycle experience.
Calendar 2025 Q4
had any update on in Japan on policyholder behavior in January or year-to-date thus far
Show response
Andy separated economic effects (FX/rates, directionally similar to 2025) from misconduct perception effects (new in 2026). Rising rates positive for yen product demand. Government incentivizing citizens to take investment risk. Surrender estimates informed by post-press release observations.
the level of outflows that you can absorb thinking about capital and liquidity and the fact that you're basically cutting off new business
Show response
Yanela confirmed no expected liquidity impact, Japan portfolio majority in JGBs. Surrender financial impact roughly $30M (20% of $150-180M). Andy noted cessation impact is small relative to 40-year in-force blocks.
Calendar 2025 Q2
now that we have a manageable range on the ESR. I'm just wondering how you might -- if you're able to sort of rank your priorities on the capital use front
Show response
Yanela confirmed capital allocation unchanged: balancing financial strength, business investment, and shareholder distributions. ESR was planned for and doesn't alter dividend capacity or cash flows.
how do the earnings -- How do the margins compare on LRT versus PRT
Show response
Yanela explained LRT is fee-based with lower capital requirements while PRT is spread-based with both longevity and asset risk. Both consistent with targeted returns. Mortality/longevity natural offset maintained. Andy cited $300B Netherlands DB-to-DC reform opportunity.
Calendar 2024 Q4
what product lines that was in and if we're seeing that big growth, like, if it's estate planning, could sales could that actually open up for a little bit more earnings volatility
Show response
Caroline confirmed growth across all products with record Q4 sales of $325M, up 60% YoY. Seeing flight to quality across industry.
PFGPrincipal Financial Group8 questions · 4 reporting periods · 1 of 8 challenging
Calendar 2026 Q3
There were reports of Samsung seeking a stake in your stock, and whether or not you wanna comment on that.
Show response
Deanna declined to comment on the report; Kamal described Korea as an attractive investing and retirement market.
how much more of a component is M and A for you strategically? But specifically, I am wondering about larger M and A.
Show response
Deanna said the M&A bar is unchanged, organic growth is primary, and Beam is the type of deal they would pursue.
Calendar 2026 Q2
is there a dynamic where there is just so much money new money going into AI and data center build outs
Show response
Kamal said PFG plays data centers as a real estate equity investor in small/mid deals, avoiding riskier private credit.
if you could kind of help quantify how this result compared to, you know, kind of a normal quarter?
Show response
Amy framed sustainability of underwriting and premium growth into H2 rather than giving a precise normalized figure.
Calendar 2026 Q1
did the M&A that you did in the quarter? Like did that contribute at all to the new business growth?
Show response
Amy confirmed small Alabama dental network acquisition including renewal rights for group benefits block was not in Q1 results. Benefits from new business, cross-sales and network optimization will start showing up in Q2 and beyond. Deanna noted good to lean into small inorganic opportunities for growth.
I'm just curious your sort of stance on that issue and how you see that heading going forward for the industry?
Show response
Chris supported privates in retirement plans citing decades of real estate experience. DOL safe harbor creates complexity around performance, fees, liquidity and valuation. Client conference with 50 largest clients showed questions and interest but no rush to adopt. Expects introduction through target date and managed account vehicles first.
Calendar 2025 Q1
you guys touch a lot of different classes. I was just wondering if you see any pockets of weakness
Show response
Kamal noted flight to conservative credit managers benefiting Principal. Increased activity in high yield, preferred, and infrastructure debt.
I was just wondering if you could comment on how you're approaching the buyback in this volatility
Show response
Joel confirmed $700M-$1B buyback guidance intact, active Q2 program in place. $200M executed in Q1. 1-cent dividend increase reflecting 9% trailing growth.
AFLAflac5 questions · 3 reporting periods · 0 of 5 challenging
Calendar 2026 Q2
if you guys have seen any change in the lapse paid up or surrender behavior given the inflationary kind of pressure and higher rates in Japan
Show response
Max Broden said there has been no significant lapse uptick from inflation or rates, with the persistency decline driven mainly by product-launch-related lapse and reissue that should normalize.
how interested you guys might be in something that could really help you leapfrog in the U.S. specifically in a diversified way
Show response
Dan Amos reiterated Aflac is always looking but focused on turning around existing programs, weighing deals against distribution fit and disciplined guidelines.
Calendar 2025 Q1
should we think about you being comfortable continuing in excess of operating income and even at this level
Show response
Max reiterated IRR-driven capital deployment framework with organic growth as top priority. Buybacks will continue where they offer good returns.
is there any anti-U.S. sentiment growing there from a trade war that could pose incremental sales challenges?
Show response
Charles Lake emphasized deep US-Japan economic relationship with Japan as largest US investor, strong alliance, and booming inbound tourism showing no anti-American impact.
Calendar 2024 Q4
how fair is it to assume that we might be relying on first sector sales maybe more heavily than we previously thought in order to reach the Japan sales targets?
Show response
Yoshizumi confirmed Tsumitasu is a hook product for third sector cross-selling. Max added there is no sales cap and the product gets very good profitability on IRR basis post-reinsurance.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| PRU Prudential Financial | 9 | 11%1 of 9 questions |
| PFG Principal Financial Group | 8 | 13%1 of 8 questions |
| AFL Aflac | 5 | 0%none of 5 questions |
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q4 | 2 | 0%none of 2 questions | 2 |
| 2025 Q1 | 4 | 0%none of 4 questions | 2 |
| 2025 Q2 | 2 | 0%none of 2 questions | 1 |
| 2025 Q3 | No questions recorded | — | — |
| 2025 Q4 | 2 | 50%1 of 2 questions | 1 |
| 2026 Q1 | 4 | 0%none of 4 questions | 2 |
| 2026 Q2 | 6 | 0%none of 6 questions | 3 |
| 2026 Q3 | 2 | 50%1 of 2 questions | 1 |
- 2024 Q42 questions · challenge rate 0% (none of 2 questions) · 2 companies
- 2025 Q14 questions · challenge rate 0% (none of 4 questions) · 2 companies
- 2025 Q22 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2025 Q3No questions recorded
- 2025 Q42 questions · challenge rate 50% (1 of 2 questions) · 1 company
- 2026 Q14 questions · challenge rate 0% (none of 4 questions) · 2 companies
- 2026 Q26 questions · challenge rate 0% (none of 6 questions) · 3 companies
- 2026 Q32 questions · challenge rate 50% (1 of 2 questions) · 1 company
Topics
Topics tagged on this analyst’s questions.
- Demand6
- M&A5
- Capital Allocation5
- Macroeconomic3
- Regulation Policy3
- Product Launch3
- Geographic Expansion2
- Revenue Growth2
- Competitive Dynamics2
- Margin2
Show all 17 topics
- Capex Investment1
- Innovation & R&D1
- Guidance Reliability1
- Labor Market1
- Fx1
- Trade Tariffs1
- Credit1